SIG
64
3
PRGO
39
2
CAT
70
-2
MMM
52
-5
NEM
42
-6
ADM
30
2
TJX
51
-3
NFLX
55
-2
ED
55
3
SCHW
49
4
DVA
75
2
AAL
62
-3
BXP
59
2
GE
81
2
AVGO
69
-7
TAP
53
5
MAC
64
2
AON
56
4
MUR
48
4
KO
50
4
SIG
64
3
PRGO
39
2
CAT
70
-2
MMM
52
-5
NEM
42
-6
ADM
30
2
TJX
51
-3
NFLX
55
-2
ED
55
3
SCHW
49
4
DVA
75
2
AAL
62
-3
BXP
59
2
GE
81
2
AVGO
69
-7
TAP
53
5
MAC
64
2
AON
56
4
MUR
48
4
KO
50
4
Financhill
Back

Brookdale Senior Living Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
34

BKD
Brookdale Senior Living

Last Price:
6.59
Seasonality Move:
-3.06%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Sell
34
Brookdale Senior Living (BKD) is a Sell

Is Brookdale Senior Living a Buy, Sell or Hold?

  • The current Brookdale Senior Living [BKD] share price is $6.59. The Score for BKD is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • BKD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BKD Stock Price Chart

What is Brookdale Senior Living's stock price today?

  • The Brookdale Senior Living share price today is $6.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BKD is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

BKD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 40.95 Sell
Chaikin Money Flow: 198589 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.61 - 7.09) Sell
Bollinger Bands (100): (6.61 - 7.39) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

BKD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.71 Sell
20-day SMA: 6.76 Sell
50-day SMA: 7.09 Sell
200-day SMA: 6.53 Buy
8-day EMA: 6.67 Sell
20-day EMA: 6.77 Sell
50-day EMA: 6.91 Sell
200-day EMA: 6.43 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

Brookdale Senior Living Earnings Growth & BKD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.09 per share, and an increase next year of $0.12 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Brookdale Senior Living Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):